Terms: = Leukemia AND IGH AND Staging
11 results:
1. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma.
Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO
J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic leukemia.
Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
[TBL] [Abstract] [Full Text] [Related]
3. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.
Boyd KD; Ross FM; Chiecchio L; Dagrada GP; Konn ZJ; Tapper WJ; Walker BA; Wardell CP; Gregory WM; Szubert AJ; Bell SE; Child JA; Jackson GH; Davies FE; Morgan GJ;
Leukemia; 2012 Feb; 26(2):349-55. PubMed ID: 21836613
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis.
Gutiérrez NC; Castellanos MV; Martín ML; Mateos MV; Hernández JM; Fernández M; Carrera D; Rosiñol L; Ribera JM; Ojanguren JM; Palomera L; Gardella S; Escoda L; Hernández-Boluda JC; Bello JL; de la Rubia J; Lahuerta JJ; San Miguel JF;
Leukemia; 2007 Jan; 21(1):143-50. PubMed ID: 17024116
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
[TBL] [Abstract] [Full Text] [Related]
6. Secondary ocular involvement in systemic "memory" B-cell lymphocytic leukemia.
Coupland SE; Foss HD; Bechrakis NE; Hummel M; Stein H
Ophthalmology; 2001 Jul; 108(7):1289-95. PubMed ID: 11425689
[TBL] [Abstract] [Full Text] [Related]
7. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques.
Pittaluga S; Tierens A; Dodoo YL; Delabie J; De Wolf-Peeters C
Am J Clin Pathol; 1999 Feb; 111(2):179-84. PubMed ID: 9930138
[TBL] [Abstract] [Full Text] [Related]
8. Structure of Bcl-1 and igh-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract] [Full Text] [Related]
9. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
[TBL] [Abstract] [Full Text] [Related]
10. [Molecular diagnosis in hematopoietic malignancy].
Hoshino A; Funato T; Sasaki T
Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of myeloid characteristics in acute lymphoblastic leukemia.
Tsuchiya H; el-Sonbaty SS; Watanabe M; Suzushima H; Asou N; Murakami T; Takeda T; Shimosaka A; Takatsuki K; Matsuda I
Leuk Res; 1993 Sep; 17(9):809-13. PubMed ID: 7690437
[TBL] [Abstract] [Full Text] [Related]
